pharmaceutical investing Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO®
FORTUNE BAY ADOPTS FORMAL ENVIRONMENTAL, SOCIAL & GOVERNANCE POLICY TO SUPPORT RESPONSIBLE PROJECT ADVANCEMENT